More Sernova News, but point missed; Close $0.265; 475k
Mr. House Positions:
Yes, agree that getting contracts completely off of the books is always a relief.
As for SVA, today's news and the weak general markets worked at cross purposes... but so goes September (and October). That said, the news was really all about a corporate update for Sernova if the details were understood enough. The SVA markets have been starved for information. Looks like Sernova's longtime buddy, ViaCyte, will Virtually run the show.
Sernova to also present Corporate Update as part of Company Presentations
London, Ontario - TheNewswire - September 10, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announced today that Dr. Philip Toleikis, President and CEO, will be a member of the Cell and Gene Therapies for Chronic Conditions panel at the virtual 2020 Cell & Gene Meeting on the Mesa. The panel session will be available on-demand to attendees as of Thursday, October 15, 2020. Dr. Toleikis will also provide an update on Sernova's clinical and research programs as part of the 2020 Company Presentations segment of the conference.
The panel will discuss the latest developments in Cell and Gene therapies for chronic conditions and will be moderated by Paul Laikind, Ph.D., President, and CEO of ViaCyte, Inc. In addition to Drs. Toleikis and Laikind, panelists are Pavan Cheruvu, M.D., CEO, Axovant Gene Therapies; Jane Lebkowski, Ph.D., President of R&D, Regenerative Patch Technologies, Inc.; and Emile Nuwaysir, Ph.D., President and CEO, BlueRock Therapeutics.
The panel will also participate in one of only two daily Live Streaming Sessions with Questions and Answers from participants on October 13, 2020 from 12:00 - 1:00pm PST.
Sernova's Corporate Update presentation will be available on-demand to attendees of the Virtual Cell & Gene Meeting on the Mesa throughout the conference. For more details on the panel and Sernova's presentation, please visit www.meetingonthemesa.com .
The puzzling part here is the selling down today by the goon squad led by 001... often kiting to 002 with 007 being a back and forth kiter.
IF SVA were a penny wonder O&G, or mining company, this type of news is akin to drilling a high impact well (Update of results) in a known production horizon (The Pouch), or exploration drilling (Update of results) in an area where excellent mining resources have already been found (The Pouch). There is almost always a very decent pop in share price because of the anticipation of "more, more, more"... BUT nada, zippo, zilch. Right from the Open, the share price was under pressure after a very brief attempt to move higher... thank you 001.
Having been in penny wonder juniors since the 1980's when you had to use a broker and there wasn't quick and easy access to information like today, I reiterate that I have never seen any trade like SVA does. I have long maintained that some entity seems to want the share price down... possibly to restrict SVA from funds like exercise of warrants???
It's still my belief that Sernova needs to forget about getting the warrants exercised and plan accordingly. The trading patterns suggest the share price is going nowhere... until news of a collaboration with $$$ attached, or an outright Buy, Bye be announced.
After 475k (207k Germany; 1k US) SVA closed at $0.265 down 1.5 cents with the general markets weak... a falling tide tends to lower all boats.